hormona glp 1 y gip GLP-1 GIP: Las hormonas que están revolucionando el control del peso y la diabetes Los agonistas del receptor GLP-1

El tratamiento de la DM tiene como objetivos asegurar al paciente una buena calidad de vida, disminuir el riesgo de complicaciones especficas (retinopata, nefropata, neuropata) y de eventos cardiovasculares (CV) que son su principal causa de mortalidad

This feature has been extensively researched in human medicine, leading to the discovery that elevated PIVKA-II serum concentrations are suggestive of specific neoplastic illnesses, including HCC, and coagulative pathologies (70)

Consistent use over time is often required to achieve the desired benefits with oral supplements

Only the functionalization with A-GSH ligands of 3-PLG-dopa or 3-PLG-ibu elevated significantly the cellular uptake indicating a lesser role in physicochemical properties like charge for these nanocarriers